Peter C. Murphy - Feb 23, 2022 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role: Chief Commercial Officer
Signature: /s/ Megan Smeykal, Attorney-in-fact
Stock symbol: TELA
Transactions as of: Feb 23, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/25/2022, 04:08 PM
Next filing: Feb 28, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TELA	Common Stock	Award	$0	+10.8K	+80.01%	$0.00	24.3K	Feb 23, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TELA	Stock Option (Right to Buy)	Award	$0	+18.6K		$0.00	18.6K	Feb 23, 2022	Common Stock	18.6K	$11.75	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2	The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.